Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04747912
Status:
RECRUITING
Last Update Posted:
2023-08-25
First Post:
2021-02-05
Brief Title:
Study of Chemotherapy-Free Induction Regimen for Ph Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin InO
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
IRB20-1749
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None